These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20579924)

  • 21. Noninvasive prenatal diagnosis: past, present, and future.
    Litton C; Stone J; Eddleman K; Lee MJ
    Mt Sinai J Med; 2009 Dec; 76(6):521-8. PubMed ID: 20014413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolution of prenatal testing: how NIPT is changing the landscape in fetal aneuploidy screening.
    Wolfberg A
    MLO Med Lab Obs; 2016 Jan; 48(1):18. PubMed ID: 26887093
    [No Abstract]   [Full Text] [Related]  

  • 23. Modifying Risk of Aneuploidy with a Positive Cell-Free Fetal DNA Result.
    Long AA; Abuhamad AZ; Warsof SL
    Clin Lab Med; 2016 Jun; 36(2):249-59. PubMed ID: 27235910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal diagnosis using fetal cells and cell-free fetal DNA in maternal blood: what is currently feasible?
    Hahn S; Holzgreve W
    Clin Obstet Gynecol; 2002 Sep; 45(3):649-56; discussion 730-2. PubMed ID: 12370604
    [No Abstract]   [Full Text] [Related]  

  • 25. From Michael to microarrays: 30 years of studying fetal cells and nucleic acids in maternal blood.
    Bianchi DW
    Prenat Diagn; 2010 Jul; 30(7):622-3. PubMed ID: 20572102
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rapid prenatal diagnosis of Down's syndrome in the first trimester of pregnancy by fluorescence in situ hybridization].
    Xiang Y; Sun N; Wang F
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):646-8. PubMed ID: 9639761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art.
    Lo YM
    BJOG; 2009 Jan; 116(2):152-7. PubMed ID: 19076946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis of common aneuploidies using quantitative fluorescent PCR.
    Bili C; Divane A; Apessos A; Konstantinos T; Apostolos A; Ioannis B; Periklis T; Florentin L
    Prenat Diagn; 2002 May; 22(5):360-5. PubMed ID: 12001187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive prenatal diagnosis: implications for antenatal diagnosis and management of high-risk pregnancies.
    Alberry MS; Soothill PW
    Semin Fetal Neonatal Med; 2008 Apr; 13(2):84-90. PubMed ID: 18249162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in fetal nucleic acids in maternal plasma.
    Lo YM
    J Histochem Cytochem; 2005 Mar; 53(3):293-6. PubMed ID: 15750005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-genomics studies and their application to non-invasive prenatal diagnosis.
    Avent ND; Plummer ZE; Madgett TE; Maddocks DG; Soothill PW
    Semin Fetal Neonatal Med; 2008 Apr; 13(2):91-8. PubMed ID: 18249591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid aneuploidy test for positive Down screening: who is willing to pay for it?
    Lo TK; Leung WC; Lau WL; Lam H; Lai FK; Ng LS; Wong WC; Chan A; Chin RK
    J Matern Fetal Neonatal Med; 2010 Jul; 23(7):747-9. PubMed ID: 19701862
    [No Abstract]   [Full Text] [Related]  

  • 33. Antenatal screening for Down Syndrome and other chromosomal abnormalities: increasingly complex issues.
    Dolk H; Wellesley D
    Arch Dis Child Fetal Neonatal Ed; 2014 Jan; 99(1):F2-3. PubMed ID: 24132715
    [No Abstract]   [Full Text] [Related]  

  • 34. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
    Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
    Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive prenatal diagnosis by single molecule counting technologies.
    Chiu RW; Cantor CR; Lo YM
    Trends Genet; 2009 Jul; 25(7):324-31. PubMed ID: 19540612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fetal DNA in maternal blood].
    Rijnders RJ; Christiaens GC; de Haas M; van der Schoot CE
    Ned Tijdschr Geneeskd; 2004 Jan; 148(4):170-4. PubMed ID: 14974307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-free fetal DNA in maternal blood: kinetics, source and structure.
    Bischoff FZ; Lewis DE; Simpson JL
    Hum Reprod Update; 2005; 11(1):59-67. PubMed ID: 15569699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prenatal diagnosis of fetal chromosomal aneuploidies using quantitative fluorescent PCR (QF-PCR)].
    Nakonieczny M; Jezierski G; Woźniak I; Liss J; Pawłowski R; Preis K; Swiatkowska-Freund M; Wójcikowski C; Łukaszuk K
    Przegl Lek; 2008; 65(3):119-21. PubMed ID: 18624118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive prenatal testing for Down syndrome.
    Twiss P; Hill M; Daley R; Chitty LS
    Semin Fetal Neonatal Med; 2014 Feb; 19(1):9-14. PubMed ID: 24210903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.